Brookstone Capital Management’s ResMed RMD Stock Holding History

Brookstone Capital Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,973	Closed	-$478K	–	824
2022 Q1	$478K	Sell	1,973 -202	-9%	-$48.9K	0.01%	573
2021 Q4	$516K	Buy	2,175 +684	+46%	+$177K	0.01%	518
2021 Q3	$376K	Sell	1,491 -314	-17%	-$85.9K	0.01%	560
2021 Q2	$449K	Buy	+1,805	New	+$379K	0.01%	504
2015 Q4	–	Sell	-500	Closed	-$25K	–	722
2015 Q3	$25K	Buy	+500	New	+$26.9K	﹤0.01%	672

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Brookstone Capital Management's RMD Position: Q2 2022 in Review

Brookstone Capital Management sold out of ResMed (RMD) in Q2 2022, closing a stake of 1,973 shares — an estimated $478K sold.

Brookstone Capital Management first reported a position in RMD in Q3 2015 and held it in 5 quarters. The position peaked at $516K in Q4 2021. 676 funds tracked by Wall St. Rank hold RMD as of Q2 2022.

Brookstone Capital Management reported no remaining ResMed position as of Q2 2022 after selling out during the quarter.
Brookstone Capital Management sold 1,973 ResMed shares in Q2 2022, an estimated $478K.
Brookstone Capital Management first reported a position in ResMed in Q3 2015 and held it in 5 quarters.
Brookstone Capital Management's ResMed position peaked at $516K in Q4 2021.
676 funds tracked by Wall St. Rank held ResMed as of Q2 2022.

Based on Brookstone Capital Management's 13F filing for Q2 2022, filed 11 Jul 2022.